| 000 | 01421 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513145826.0 | ||
| 264 | 0 | _c19980730 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.51.1.274 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiamond, S | |
| 245 | 0 | 0 |
_aSerotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. _h[electronic resource] |
| 260 |
_bNeurology _cJul 1998 |
||
| 300 |
_a274-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCentral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCyclohexanols _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPhenelzine _xadverse effects |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aVenlafaxine Hydrochloride |
| 700 | 1 | _aPepper, B J | |
| 700 | 1 | _aDiamond, M L | |
| 700 | 1 | _aFreitag, F G | |
| 700 | 1 | _aUrban, G J | |
| 700 | 1 | _aErdemoglu, A K | |
| 773 | 0 |
_tNeurology _gvol. 51 _gno. 1 _gp. 274-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.51.1.274 _zAvailable from publisher's website |
| 999 |
_c9640684 _d9640684 |
||